Pneumonia Pathophysiology
Pneumonia Pathophysiology - Related Videos
01:29
Pneumonia II: Pathophysiology
0 Views •
2024
The pathophysiology of pneumonia involves the following steps: • Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract. • Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly virulent,...
09:17
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
0 Views •
Cited by 17 •
2017
A method for establishing lung infections in immunocompetent rodents is described. With proficiency, this method can be performed quickly and easily to induce stable infection with many isolates of S. pneumoniae, H. influenzae, P. aeruginosa, K. pneumoniae and A. baumannii.
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
0 Views •
Cited by 50 •
2014
Pneumonia is one of the top ten leading causes of death in the U.S. Osteopathic manipulative techniques (OMT) may be utilized as an adjunctive therapy in the treatment of pneumonia to enhance biomechanical and immune function; and ultimately, to reduce hospital stay, duration of antibiotics, incidence of respiratory failure, and mortality. In this video-article, we will review randomized controlled studies on the use of OMT in pneumonia patients, as well as demonstrate specific hands-on...
03:14
Microaerobic Fermentation of Bamboo Hydrolysate by Klebsiella pneumoniae
0 Views •
2025
Source: Wei, D., et al., Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock. J. Vis. Exp. (2017)This video demonstrates the microbial conversion of bamboo-derived sugars into 2,3-butanediol by culturing Klebsiella pneumoniae in a hydrolysate-based medium under microaerobic and mildly acidic conditions.
07:24
Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
0 Views •
Cited by 1 •
2017
Bamboo powder was pretreated with NaOH and enzymatically hydrolyzed. The hydrolysate of bamboo was used as the feedstock for 2,3-butanediol, R-acetoin, 2-ketogluconic acid, and xylonic acid production by Klebsiella pneumoniae.
FAQs
After microorganisms or another inflammatory trigger reaches the lower respiratory tract, innate immune defenses become activated. This response promotes leukocyte accumulation and increases fluid within the alveoli, producing edema. As inflammatory material collects, affected air spaces become consolidated rather than remaining normally air-filled. These changes connect the immune response directly to impaired pulmonary function and clinical illness.
Consolidated, fluid-filled alveoli receive less effective ventilation while pulmonary blood flow may continue through affected regions. This creates a mismatch between ventilation and perfusion, reducing the efficiency of oxygen transfer into the blood. The resulting hypoxemia can increase the work of breathing, helping explain why respiratory symptoms become more pronounced as inflammatory involvement expands.
Severity depends on the characteristics of the pathogen or trigger, the effectiveness of host defenses, and the presence of comorbidities. These factors influence how strongly inflammation develops and how well the lungs tolerate impaired gas exchange. More severe disruption can progress from hypoxemia and increased breathing effort to respiratory failure or contribute to sepsis.
These symptoms reflect different consequences of the same inflammatory process. Innate immune activation is associated with fever, while inflammation and material within the alveoli contribute to cough. Reduced oxygen diffusion, ventilation-perfusion mismatch, and increased work of breathing produce dyspnea. Considering the symptoms together helps relate bedside findings to the underlying pulmonary injury rather than viewing them separately.
Mechanistic findings help clinicians interpret the significance of alveolar edema, leukocyte accumulation, consolidation, impaired oxygen diffusion, and ventilation-perfusion mismatch. The extent of these changes provides context for symptoms and hypoxemia, while pathogen characteristics, host defenses, and comorbidities help estimate severity. This framework supports clinical diagnosis and recognition of patients at risk for respiratory failure or sepsis.
Treatment selection can be guided by the infectious or inflammatory processes damaging the lung and by the severity of gas-exchange impairment. Risk assessment focuses on whether inflammation and consolidation may progress to respiratory failure or sepsis. The same understanding also supports prevention strategies by identifying the importance of pathogen-related risk, host defenses, and underlying comorbidities.